Lunai Bioworks Inc. — Director's Dealing 2017

Oct 20, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DanDrit Biotech USA, Inc. (DDRT)
CIK: 0001527728
Period of Report: 2017-10-09

Reporting Person: Gronfeldt-Sorensen Henrik (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants to purchase shares of common stock	$2.00	2019-12-31	Common Stock (50000)		Indirect

Footnotes

F1: Mr. Sorensen was appointed as a director on October 9, 2017. On October 13, 2017, Greenfield Holding ApS, a Danish limited company controlled by Mr. Sorensen, purchased warrants to purchase up to 50,000 shares of common stock in DanDrit Biotech USA, Inc. in a private transaction.